Please enable Javascript to use all features and improve your user experience.
EHC 2024
Programme
Posters
Search
EN
Back
ePoster
P168
Long-term sustained response of Atogepant in episodic and chronic migraine: an interim analysis of a phase 3, open-label, 156-week safety extension study
Patricia Pozo-Rosich
Barcelona, ES
Appointment
Date:
05.12.
Time:
11:10
–
11:15
Talk time:
3 Min.
Discussion time:
2 Min.
Location / Stream:
ePoster station 8
Poster
Long-term sustained response of Atogepant in episodic and chronic migraine: an interim analysis of a phase 3, open-label, 156-week safety extension study
Session
ePoster 08
Topic
Migraine
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy